HuGE Literature Finder
Records
1
-
4
Differences in Genomic Alterations Between Brain Metastases and Primary Tumors. Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes. Oncology letters 2016 Nov 12 (5): 3312-3322. Cai Yi-Ran, Dong Yu-Jie, Wu Hong-Bo, Yu Da-Ping, Zhou Li-Juan, Su Dan, Zhang Li, Chen Xue-Ji |
A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer. Oncotarget 2016 May 7 (18): 25632-9. Sacher Adrian G, Le Lisa W, Lara-Guerra Humberto, Waddell Thomas K, Sakashita Shingo, Chen Zhuo, Kim Lucia, Zhang Tong, Kamel-Reid Suzanne, Salvarrey Alexandra, Darling Gail, Yasufuku Kazuhiro, Keshavjee Shaf, de Perrot Marc, Shepherd Frances A, Liu Geoffrey, Tsao Ming Sound, Leighl Natasha |
Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status. Biomedical reports 2014 Jul 2 (4): 481-489. Yu DA-Ping, Dong Yu-Jie, Zhang Hai-Qing, Wang Jing-Hui, Qu Yang, Zhou Li-Juan, Su Dan, Zhang Li-Li, Zhao Dan, Cai Yi-R |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 01, 2023
- Content source: